Skip to main content
VivoSim Labs, INC. logo

VivoSim Labs, INC. — Investor Relations & Filings

Ticker · VIVS ISIN · US68620A2033 US Professional, scientific and technical activities
Filings indexed 790 across all filing types
Latest filing 2018-07-30 Director's Dealing
Country US United States of America
Listing US VIVS

About VivoSim Labs, INC.

https://organovo.com/

VivoSim Labs, Inc. is a biotechnology services company that develops and utilizes bioprinted, three-dimensional (3D) human tissues designed to emulate human biology and disease. The company provides testing services for drugs and drug candidates, primarily for the pharmaceutical and biotechnology sectors. VivoSim Labs specializes in offering liver and intestinal toxicology insights through its proprietary New Approach Methodologies (NAMs), including its NAMkind™ 3D models. These non-animal testing platforms are used to generate human-relevant safety and toxicology data early in the drug discovery and development process, aiming to provide insights before animal studies or clinical trials.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2018-07-30 English
8-K (ANNUAL MEETING RESULTS)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 26, 2018, reporting the results of the Annual Meeting of Stockholders of Organovo Holdings, Inc. It details the voting outcomes on various proposals including election of directors, ratification of auditors, increase in authorized shares, amendment of equity incentive plan, and executive compensation. The document includes detailed vote counts and descriptions of the proposals voted on. This type of filing corresponds to the official results from shareholder votes at a general meeting, which matches the category 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is not a full annual report, proxy statement, or management discussion, but specifically the voting results from the AGM. Therefore, the correct classification is DVA with high confidence.
2018-07-27 English
FORM 4 SUBMISSION
Director's Dealing
2018-06-26 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive additional proxy statement material related to the Annual Meeting of shareholders. It includes information about the meeting date, proposals to be voted on, and instructions for accessing proxy materials. It is not the proxy statement itself but additional materials related to it. This fits the category of Proxy Solicitation & Information Statement (PSI), as it is designed to provide shareholders with information and solicit votes for the meeting. The document is about 4935 characters, which is consistent with a detailed proxy solicitation document rather than a brief announcement or a full annual report. Therefore, the correct classification is PSI with high confidence.
2018-06-15 English
DEF 14A
Proxy Solicitation & Information Statement
2018-06-15 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically for the Annual Meeting of Stockholders of Organovo Holdings, Inc. It includes detailed information about the meeting agenda, proposals to be voted on, board of directors information, corporate governance, and executive compensation practices. The document is not a full annual report or financial statement but rather materials sent to shareholders to provide information and solicit votes for the annual meeting. The presence of voting proposals, director elections, and compensation advisory votes confirms it is a Proxy Solicitation & Information Statement. The document length (15,000 characters) and content confirm it is the actual proxy statement, not just an announcement or summary. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2018-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.